Project Details
Description
A Phase I Pharmacodynamic Study of CP-751,871 as Neoadjuvant Treatment For Early Breast Cancer (A4021012) [SPA NOTE: fka/aka Identification of Biomarkers to IGF-1R Activity in a Phase II Neoadjuvant Trial]
Status | Finished |
---|---|
Effective start/end date | 12/21/05 → 7/31/11 |
Funding
- PFIZER, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.